Canada markets closed

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3831-0.0030 (-0.77%)
At close: 3:58PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
8,953
8,017
9,582
891.677
-
Cost of Revenue
820.502
1,009
7,147
594.313
-
Gross Profit
8,132
7,008
2,436
297.364
-
Operating Expenses
Research Development
929.33
1,526
3,733
-
-
Selling General and Administrative
26,318
28,410
35,913
20,194
-
Total Operating Expenses
27,973
30,613
40,016
20,194
-
Operating Income or Loss
-19,840
-23,605
-37,580
-19,896
-
Total Other Income/Expenses Net
-372.17
-344.916
1,225
168.376
-
Income Before Tax
-20,212
-23,950
-36,355
-19,728
-
Income Tax Expense
83.788
88.983
22.746
78.58
-
Income from Continuing Operations
-20,296
-24,039
-36,378
-19,807
-
Net Income
-20,296
-24,039
-36,378
-19,807
-
Net Income available to common shareholders
-20,296
-24,039
-36,378
-19,528
-
Basic EPS
-
-0.20
-0.36
-0.42
-0.14
Diluted EPS
-
-0.20
-0.36
-0.42
-0.14
Basic Average Shares
-
120,294
101,966
48,519
27,757
Diluted Average Shares
-
120,294
101,966
48,519
27,757
EBITDA
-
-22,438
-36,641
-19,558
-